Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.
Heart icon (animated) heart icon (static)
Explore more Johnson & Johnson sites:
Our Company


Today's Top Reads Close

A word or two on rumors and speculation.

Johnson & Johnson is well-known for its aggressive acquisition strategy, and as such, there are often rumors circulating about whether we are going to make a bid for company X, or do a deal with company Y.

When asked about these rumors, I almost always have nothing to say. We just don’t comment on rumors and speculation. Period.

Reporters often ask if we could just signal them “off the record” as to whether there is any truth to the rumor. On the record or off, our answer remains the same. If I were to whisper to a reporter that there’s nothing to what they are hearing, what happens the next time they call and don’t receive the same whisper? If we are in talks regarding an acquisition, such discussions are kept confidential for good reason. A deal is not a deal until it is signed, sealed and delivered.

After declining to comment on an acquisition rumor, I’m often asked if I would simply talk about our acquisition philosophy in general -- what types of companies or technologies Johnson & Johnson would like to acquire.

Again, in the context of a question about a specific rumor, how can I discuss our acquisition philosophy and strategy without seemingly tipping our hand or fueling speculation?

The reality is that with such a broad portfolio of businesses, our business development teams cast a wide net.

My understanding is that they are always on the look out for companies, products or emerging technologies that will complement our existing franchises or further our strategy for growing the business.

Back to top
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.